Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes
- PMID: 12438314
- DOI: 10.1074/jbc.M210581200
Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes
Abstract
We have proposed that hyperglycemia-induced dedifferentiation of beta-cells is a critical factor for the loss of insulin secretory function in diabetes. Here we examined the effects of the duration of hyperglycemia on gene expression in islets of partially pancreatectomized (Px) rats. Islets were isolated, and mRNA was extracted from rats 4 and 14 weeks after Px or sham Px surgery. Px rats developed different degrees of hyperglycemia; low hyperglycemia was assigned to Px rats with fed blood glucose levels less than 150 mg/dl, and high hyperglycemia was assigned above 150 mg/dl. beta-Cell hypertrophy was present at both 4 and 14 weeks. At the same time points, high hyperglycemia rats showed a global alteration in gene expression with decreased mRNA for insulin, IAPP, islet-associated transcription factors (pancreatic and duodenal homeobox-1, BETA2/NeuroD, Nkx6.1, and hepatocyte nuclear factor 1 alpha), beta-cell metabolic enzymes (glucose transporter 2, glucokinase, mitochondrial glycerol phosphate dehydrogenase, and pyruvate carboxylase), and ion channels/pumps (Kir6.2, VDCC beta, and sarcoplasmic reticulum Ca(2+)-ATPase 3). Conversely, genes normally suppressed in beta-cells, such as lactate dehydrogenase-A, hexokinase I, glucose-6-phosphatase, stress genes (heme oxygenase-1, A20, and Fas), and the transcription factor c-Myc, were markedly increased. In contrast, gene expression in low hyperglycemia rats was only minimally changed at 4 weeks but significantly changed at 14 weeks, indicating that even low levels of hyperglycemia induce beta-cell dedifferentiation over time. In addition, whereas 2 weeks of correction of hyperglycemia completely reverses the changes in gene expression of Px rats at 4 weeks, the changes at 14 weeks were only partially reversed, indicating that the phenotype becomes resistant to reversal in the long term. In conclusion, chronic hyperglycemia induces a progressive loss of beta-cell phenotype with decreased expression of beta-cell-associated genes and increased expression of normally suppressed genes, these changes being present with even minimal levels of hyperglycemia. Thus, both the severity and duration of hyperglycemia appear to contribute to the deterioration of the beta-cell phenotype found in diabetes.
Similar articles
-
Genetic regulation of metabolic pathways in beta-cells disrupted by hyperglycemia.J Biol Chem. 2002 Mar 29;277(13):10912-21. doi: 10.1074/jbc.M111751200. Epub 2002 Jan 8. J Biol Chem. 2002. PMID: 11782487
-
Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to beta-cell survival during chronic hyperglycemia.Diabetes. 2002 Feb;51(2):413-23. doi: 10.2337/diabetes.51.2.413. Diabetes. 2002. PMID: 11812749
-
Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes.J Biol Chem. 1999 May 14;274(20):14112-21. doi: 10.1074/jbc.274.20.14112. J Biol Chem. 1999. PMID: 10318828
-
Beta-cell adaptation and decompensation during the progression of diabetes.Diabetes. 2001 Feb;50 Suppl 1:S154-9. doi: 10.2337/diabetes.50.2007.s154. Diabetes. 2001. PMID: 11272180 Review.
-
Rapid correction of chronic hyperglycemia and bone remodeling, warning against overdoing.World J Diabetes. 2024 Sep 15;15(9):1858-1861. doi: 10.4239/wjd.v15.i9.1858. World J Diabetes. 2024. PMID: 39280185 Free PMC article. Review.
Cited by
-
The role of membrane excitability in pancreatic β-cell glucotoxicity.Sci Rep. 2019 May 6;9(1):6952. doi: 10.1038/s41598-019-43452-8. Sci Rep. 2019. PMID: 31061431 Free PMC article.
-
Glucose Driven Changes in Beta Cell Identity Are Important for Function and Possibly Autoimmune Vulnerability during the Progression of Type 1 Diabetes.Front Genet. 2017 Jan 24;8:2. doi: 10.3389/fgene.2017.00002. eCollection 2017. Front Genet. 2017. PMID: 28174593 Free PMC article.
-
Pancreatic β-cell heterogeneity in health and diabetes: classes, sources, and subtypes.Am J Physiol Endocrinol Metab. 2021 Apr 1;320(4):E716-E731. doi: 10.1152/ajpendo.00649.2020. Epub 2021 Feb 15. Am J Physiol Endocrinol Metab. 2021. PMID: 33586491 Free PMC article. Review.
-
Nutrient induced type 2 and chemical induced type 1 experimental diabetes differently modulate gastric GLP-1 receptor expression.J Diabetes Res. 2015;2015:561353. doi: 10.1155/2015/561353. Epub 2015 Mar 29. J Diabetes Res. 2015. PMID: 25893200 Free PMC article.
-
Pancreatic β-cell identity in diabetes.Diabetes Obes Metab. 2016 Sep;18 Suppl 1(Suppl 1):110-6. doi: 10.1111/dom.12727. Diabetes Obes Metab. 2016. PMID: 27615139 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous